North Eastern Bio-Refinery Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-12-2024
- Paid Up Capital ₹ 1.50 M
as on 15-12-2024
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About North Eastern Bio-Refinery
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Debasish Dey, Samit Dutta, Subrata Dutta, and Three other members serve as directors at the Company.
- CIN/LLPIN
U15490WB2022PTC256539
- Company No.
256539
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2022
- Date of AGM
31 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Dinajpur, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at North Eastern Bio-Refinery?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debasish Dey  | Director | 22-Aug-2022 | Current |
| Samit Dutta | Director | 22-Aug-2022 | Current |
| Subrata Dutta | Director | 22-Aug-2022 | Current |
| Kunal Kumar | Director | 22-Aug-2022 | Current |
| Kamalesh Chanda | Director | 22-Aug-2022 | Current |
| Bhola Paul | Additional Director | 30-Sep-2023 | Current |
Financial Performance of North Eastern Bio-Refinery.
North Eastern Bio-Refinery Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of North Eastern Bio-Refinery?
Unlock access to North Eastern Bio-Refinery's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Chemwood Udyog Private LimitedActive 5 years 2 monthsDebasish Dey and Samit Dutta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at North Eastern Bio-Refinery?
North Eastern Bio-Refinery has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of North Eastern Bio-Refinery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped North Eastern Bio-Refinery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
